Quality use of generic medicines

Australian Prescriber

Volumn 27, Issue 4, 2004, Pages 80-81

  Hassali, Azmi ^a   Stewart, Kay ^a   Kong, David ^b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Consumers; Drug industry; Drug regulation; National Medicines Policy

Indexed keywords

AUSRAN; GENERIC DRUG; RANI2; RANIHEXAL; RANITIDINE; RANITIDINE BC; RANOXYL;

AUSTRALIA; COMPUTER PROGRAM; CONSUMER; DRUG COST; DRUG INDUSTRY; DRUG QUALITY; DRUG USE; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; PUBLICATION; TREATMENT OUTCOME;

EID: 3543017367     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2004.067     Document Type: Editorial

References (6)

1. King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J 2002;43:462-9.
2. Smeaton J. The generics market. Aust J Pharm 2000;81: 540-2.
3. National Medicines Policy 2000. Canberra: Commonwealth Department of Health and Aged Care; 2000.
4. Lockney A. Generic medicines. inPHARMation (Pharmaceutical Society of Australia) 2003;4:6-10.
5. Burton B. Changing prescription software to favour generics could save Australia £40m a year. Br Med J 2003;326:184.
6. Birkett DJ. Generics - equal or not? Aust Prescr 2003;26:85-7.